Stock Insiders is a podcast series focussed on investing, hosted by TV presenter and news journalist Christina Morrissy.

In this episode Christina chats to CEO + Managing Director at Optiscan Imaging Ltd (ASX:OIL) Dr Camile Farah, is also a trained clinician and pathologist.

Optiscan is a global leader in the development, manufacturing, and commercialisation of confocal endomicroscopic imaging technologies for medical, translational and pre-clinical applications. Their technology enables real-time, non-destructive, 3D, in-vivo digital imaging at the single-cell level.

The technology development is designed for earlier diagnosis and subsequent treatment of cancerous tumours with expected associated improved patient outcomes. It could also help alleviate concerns about a growing shortage of pathologists in Australia and internationally delaying medical test results.

To hear Christina and Camile discuss all this and more, tune in below!

On mobile? Click here to listen with Apple podcasts, here for Spotify.

Like to tune in through another app? Just search for Stock Insiders with Christina Morrissy and subscribe!